WellesleyWeston Magazine

SPRING 2013

Launched in 2005, WellesleyWeston Magazine is a quarterly publication tailored to Wellesley and Weston residents and edited to enrich the experience of living in two of Massachusetts' most desirable communities.

Issue link: http://wellesleywestonmagazine.epubxp.com/i/107826

Contents of this Issue

Navigation

Page 72 of 203

DEDICATED TO SCIENTIFIC DISCOVERY AARON WASHINGTON L I Z S U N E B Y writer cancer survivor Kelley Tuthill addressed a group of 250 women gathered at the Wellesley Country Club for the fourth Susan F. Smith Center for Women's Cancers Executive Council's Beyond Boston Luncheon. For Christmas 2006 the only gift I wanted was to live long enough for my two-and-a-half-year-old and six-month-old children to know me…and remember me. That was something I had taken for granted until I was diagnosed with aggressive breast cancer at age 36. Six years ago, I thought I had it all. I had just given birth to my second daughter. Happily married and about to celebrate my fifth wedding anniversary. The dream job as a reporter at Channel 5 here in Boston. I spent 2007 having a mastectomy, reconstruction, sixteen weeks of chemotherapy, six weeks of radiation, and a year of Herceptin followed by five years of Tamoxifen. It was a lot, [but] I was blessed to have so many therapies available to me, especially Herceptin. That's one of those targeted therapies developed specifically for my aggressive type of cancer. I want to shout from the rooftops so people understand the kind of cutting edge treatment that Dana Farber provides…and the comfort it is to be a patient knowing you have every advantage at your disposal to beat your disease. Thankfully for Kelley and all of us, there are scientists, many right here in Greater Boston, advancing science and the commercial application of science to improve human health. These doctors, driven to unlock the mysteries of biology, toil for years in hopes of targeting the root causes of diseases in order to develop cures. They work tirelessly in the lab and with patients—from the "bench" to the "bedside." It's not a job for people who thrive on instant results or sure bets. "Only five PETER BAKER says Wellesley's Dr. Michael Vasconcelles, Senior Vice President and Head of Oncology Clinical Development at Millennium: The Takeda Oncology Company, a biopharmaceutical company focused solely on developing cures for cancer, particularly lymphomas (including multiple myeloma), breast, 71 s p r i n g 2 0 1 3 | We l l e s l e y We s t o n M a g a z i n e percent of cancer drugs tested in clinical trials actually achieve FDA approval,"

Articles in this issue

Archives of this issue

view archives of WellesleyWeston Magazine - SPRING 2013